Market research
DN.TO Delta 9 Cannabis Inc
TO CAD Healthcare
Latest close
As of 29 Dec 2024
Test a moving-average rule with historical data.
Market facts
- Market cap
- 3M
- P/E ratio
- Not available
- Analyst target
- 0.8
- Dividend yield
- Not available
- Beta
- 1.21
Profile
Instrument facts
- Exchange
- TO
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA2477541049
- Market cap
- 3M
- P/E ratio
- Not available
- Analyst target
- 0.8
- Dividend yield
- Not available
- Beta
- 1.21
About
About Delta 9 Cannabis Inc
Delta 9 Cannabis Inc., together with its subsidiaries, operates as an integrated cannabis company. The company engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. The company operates retail stores under the Delta 9 brand name across the Canadian provinces. It also exports its products to Australia. The company was incorporated in 2001 and is based in Vancouver, Canada.
Research context
Delta 9 Cannabis Inc appears in PyInvesting’s Toronto Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the DN.TO discussion.
5 years, 6 months ago
Delta 9 Cannabis Inc is currently in a long term downtrend where the price is trading 17.8% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
Delta 9 Cannabis Inc's total revenue rose by 24.0% to $13M since the same quarter in the previous year.
Its net income has dropped by 1989.4% to $-6M since the same quarter in the previous year.
Finally, its free cash flow grew by 60.3% to $-1M since the same quarter in the previous year.
Based on the above factors, Delta 9 Cannabis Inc gets an overall score of 3/5.